This protocol is judged by an institutional critique board, an impartial team that critiques any medical trials involving humans. If a study will involve a Routine I drug, as soon as the board approves the protocol as moral, the scientists need to apply for an investigational new drug (IND) selection from your FDA. Encounter a straightforward 4-